1. Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-g inhibition;Apostolova;Trends in Pharmacological Sciences,2011
2. Dziuban, E.J., Raizes, E., Koumans, E.H., 2014. A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine. International Journal of STD & AIDS, in press. http://dx.doi.org/10.1177/0956462414554433.
3. Differential kinetics of transport of 2’,3’-dideoxyinosine and adenosine via concentrative Na+ nucleoside transporter CNT2 cloned from rat blood–brain barrier;Li;Journal of Pharmacology and Experimental Therapeutics,2001
4. Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease;Perry;Drugs,1996
5. Didanosine: An updated review of its use in HIV infection;Perry;Drugs,1999